Pepgen Inc (PEPG) Stock Price, Quote & News

Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 797 0979

Website: pepgen.com

Address:

321 Harrison Avenue, 8th Floor, Boston, United States

YouVSYou Sep. 14 at 1:37 PM

September has been fun so far FOMC this week What’s your thoughts $SPY $OPEN $QQQ $QMMM $PEPG

2 · Reply

wingg Sep. 12 at 1:45 PM

$PEPG $RZLV

0 · Reply

YouVSYou Sep. 12 at 1:45 PM

$RZLV bulls win. How bout those dips $PEPG next

0 · Reply

Jefcud Sep. 12 at 1:37 PM

$PEPG this one Will fly soon, in now

0 · Reply

elmono Sep. 10 at 8:02 PM

$CLRB $PEPG nice f’ing sell off today 👏👏👏👏

0 · Reply

BiotechValues Sep. 10 at 4:11 PM

$PEPG Gugg confirms company will issue a press release and hold CC BEFORE Oct 11 full data. So data 3-4 weeks out. "Key upcoming clinical readouts: (1) 15 mg/kg SAD data, to be presented at the WMS on October 11, 2025, with a PR/call prior; and (2) 5 mg/kg MAD data during 1Q26."

1 · Reply

BiotechValues Sep. 10 at 4:11 PM

$PEPG from Gugg initiation yesterday $6 PT BUY: "The stock could trade higher by 10x from current levels by 1H26, should ongoing clinical data validate PEPG’s differentiated approach."

0 · Reply

NVDAMillionaire Sep. 10 at 7:49 AM

$PEPG Outstanding article that hits the mark on PEPG's current state. So if you want to refresh your PEPG insights or learn about PEPG from scratch, this is a must read. https://beyondspx.com/quote/PEPG/analysis/pepgen-s-reimagined-future-edo-platform-drives-dm1-ambition-after-dmd-setback-nasdaq-pepg

0 · Reply

JarvisFlow Sep. 9 at 1:00 PM

Guggenheim has updated their rating for PepGen ( $PEPG ) to Buy with a price target of 6.

0 · Reply

boomshiva Sep. 9 at 12:59 PM

$PEPG 👀

0 · Reply

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Jul 30, 2025, 5:41 PM EDT - 6 weeks ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 29, 2025, 10:33 AM EDT - 6 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 23, 2025, 11:22 AM EDT - 7 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jun 23, 2025, 9:00 AM EDT - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Jun 16, 2025, 10:39 AM EDT - 3 months ago

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

Jun 10, 2025, 10:44 AM EDT - 3 months ago

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

May 29, 2025, 9:19 AM EDT - 3 months ago

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

May 28, 2025, 6:21 PM EDT - 3 months ago

PepGen to discontinue development of experimental Duchenne therapy; shares drop

May 28, 2025, 4:05 PM EDT - 3 months ago

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

May 20, 2025, 7:00 AM EDT - 4 months ago

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

May 8, 2025, 8:00 AM EDT - 4 months ago

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Apr 2, 2025, 4:05 PM EDT - 5 months ago

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 31, 2025, 4:05 PM EDT - 5 months ago

PepGen Announces Appointment of Two New Directors to its Board

Mar 10, 2025, 4:05 PM EDT - 6 months ago

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Mar 4, 2025, 1:41 PM EST - 6 months ago

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls

Mar 4, 2025, 8:05 AM EST - 6 months ago

PepGen to Participate in Upcoming Investor Conferences

Mar 4, 2025, 8:00 AM EST - 6 months ago

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD

Feb 24, 2025, 7:30 AM EST - 7 months ago

PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights

Feb 24, 2025, 7:00 AM EST - 7 months ago

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

Jan 29, 2025, 4:05 PM EST - 8 months ago

PepGen Announces CONNECT Program Updates

Dec 16, 2024, 8:00 AM EST - 9 months ago

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy

Nov 21, 2024, 4:05 PM EST - 10 months ago

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development

Nov 7, 2024, 8:00 AM EST - 11 months ago

PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Oct 8, 2024, 7:00 AM EDT - 1 year ago

PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society

YouVSYou Sep. 14 at 1:37 PM

September has been fun so far FOMC this week What’s your thoughts $SPY $OPEN $QQQ $QMMM $PEPG

2 · Reply

wingg Sep. 12 at 1:45 PM

$PEPG $RZLV

0 · Reply

YouVSYou Sep. 12 at 1:45 PM

$RZLV bulls win. How bout those dips $PEPG next

0 · Reply

Jefcud Sep. 12 at 1:37 PM

$PEPG this one Will fly soon, in now

0 · Reply

elmono Sep. 10 at 8:02 PM

$CLRB $PEPG nice f’ing sell off today 👏👏👏👏

0 · Reply

BiotechValues Sep. 10 at 4:11 PM

1 · Reply

BiotechValues Sep. 10 at 4:11 PM

$PEPG from Gugg initiation yesterday $6 PT BUY: "The stock could trade higher by 10x from current levels by 1H26, should ongoing clinical data validate PEPG’s differentiated approach."

0 · Reply

NVDAMillionaire Sep. 10 at 7:49 AM

0 · Reply

JarvisFlow Sep. 9 at 1:00 PM

Guggenheim has updated their rating for PepGen ( $PEPG ) to Buy with a price target of 6.

0 · Reply

boomshiva Sep. 9 at 12:59 PM

$PEPG 👀

0 · Reply

SDBiotechInvestor Aug. 28 at 6:33 PM

$CYCN Joel has 35k shares now. Gave up on $BCAB and $PEPG LMAOOOO

0 · Reply

SDBiotechInvestor Aug. 20 at 5:14 PM

$CYCN - With the market topping this week and tech plummeting ,$CYCN is a great place to park your money for TRD inlicense news. No downside, whereas you see $BOLT and $PEPG bleed daily. If my theory of beacon biosignals is correct, when the announcement comes sky is the limit.

0 · Reply

hbkstockislife Aug. 14 at 3:55 PM

$PEPG tutes sold and this gets pump ..weird

0 · Reply

hbkstockislife Aug. 14 at 3:31 PM

$PEPG running

0 · Reply

sogenerous Aug. 14 at 3:13 PM

$PEPG interesting name trading at negative valuation to cash - some small insider buys , low float, down 90%+ may get 10k as spec position @Monkey_Banana_Genius thoughts?

1 · Reply

AnalyticaInvestor Aug. 4 at 10:50 AM

$SLP $RCKT $PEPG $QMCO 🧬 Biotech & Tech Bounceback? $SLP, $PEPG, $RCKT all down 50–75%+ YTD but showing signs of life. From AI-driven drug discovery to gene therapy breakthroughs, these high-risk plays are drawing fresh attention. $QMCO popped 10% despite an –86% YTD collapse, reminding investors that small caps can move fast in both directions. Catching a falling knife or finding deep value? 📊 Read the full Analytica Investor for all the insights 👇 https://analyticainvestor.beehiiv.com/p/you-re-fired-3502b8c8dd61d73c

1 · Reply

XkaliburTrading Aug. 3 at 1:11 PM

$PEPG https://newsfilter.io/articles/pepg-investors-have-the-opportunity-to-lead-the-pepgen-securities-fraud-lawsuit-with-faruqi-amp-faru-cf39ccfda3901a0578d5845d8736dc03

0 · Reply

XkaliburTrading Jul. 30 at 10:32 PM

$PEPG https://newsfilter.io/articles/shareholder-notice-faruqi-amp-faruqi-llp-investigates-claims-on-behalf-of-investors-of-pepgen-76badb161ad34bd3adf1e84039119b91

0 · Reply

Fib7867 Jul. 29 at 2:37 AM

#myPEPGanalysis $PEPG

0 · Reply

11thestate Jul. 25 at 5:29 AM

$PEPG stockholders filed a claim against PepGen for allegedly overstating the safety of its DMD drug PGN-EDO51 and hiding regulatory risks and trial setbacks. You can join this case to be notified about any new information: https://11th.com/cases/pepgen-investor-suit

0 · Reply

ae_savant Jul. 23 at 5:07 PM

$FLO Just moved above 21 EMA and other chart features looking positive. 6.5% divy payer restructuring for healthy food snacks. Worth a look. $PG $HNST $KHI $PEPG

0 · Reply

stivelpsu Jul. 23 at 2:50 AM

$PEPG any news on this one due out soon?

0 · Reply

Market Cap	48.54M
Revenue (ttm)	0.00
Net Income (ttm)	-89.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	557,500
Avg Vol	322,958
Day's Range	N/A - N/A
Shares Out	32.80M
Stochastic %K	46%
Beta	1.17
Analysts	Strong Sell
Price Target	$6.83